Fresenius Kabi Hungary

Company description

Fresenius Kabi a pharmaceutical company specializing in the treatment of patients with severe and chronic.

The Fresenius Kabi Hungary in Fresenius SE & Co. KGaA, Fresenius Kabi division’s Hungarian subsidiary. activity of ours is the most severe and in ambulatory patients with volume therapy, parenteral and enteral nutrition, intravenous anesthesia, oncology, antibiotics, pain therapy, nephrology is involved. Our products are our own and through other wholesale supply to the users.

Interview with Denisa Timkova, General Manager, Cegedim Hungary

Talking to Cegedim means talking to one of the experts in local market knowledge. Can you tell our readers from your point of view what really distinguishes Hungary from other…

Interview with Gabor Zalai, General Manager, Boehringer Ingelheim Hungary

Looking at Boehringer Ingelheim (BI) in Hungary, at first glance we see a company with a presence of already 20 years, which basically means an entry into this market right…

Interview with Christophe Gourlet, CEO, Sanofi-aventis Hungary

Sanofi for 3,5 years. It must have been quite a different market, culture and environment. Yet, at that time you publicly announced that it only took you 30 seconds to…

Erik Bogsch – Managing Director, Gedeon Richter

Gedeon Richter’s Erik Bogsch discusses the company’s 100th anniversary, it’s growing international footprint and the future of Hungarian pharma. Gedeon Richter is known to be the flagship pharmaceutical company…

Interview with Morten Vaupel, General Manager, Novo Nordisk Hungary

We understand that you have been with Novo Nordisk for quite a while already. In the past decade, you also did not sit still in terms of location, working in…

Interview with Andras Gizur, Chief Representative, Gedeon Richter

Since establishing Gedeon Richter’s operations here 16 years ago, you’ve been involved in the full array of the pharmaceutical spectrum, from R&D, sourcing API, sales and marketing of finished products,…